All blog items

Allan Kirk is about as thoroughly steeped in Duke Blue as it is possible to be: the son of a Duke-trained biologist, he earned both his MD and PhD at Duke, did his residency in surgery at Duke (serving as chief resident), and eventually joined the faculty at Duke. He even married a Duke nurse, and his children were born at Duke. In all his roles at Duke, he has demonstrated the leadership, scientific and medical excellence, and vision that exemplify the institution’s traditions and goals.

Racial and ethnic minorities frequently encounter barriers when accessing health care, but radiation oncologist Karen Winkfield aims to change that, making it her mission to break down those barriers and become a champion for health equity for all.

Anna Mae Diehl is a pioneer and international leader in the field of liver growth and pathobiology. Colleagues describe her work as marked by persistence and inspiration. She has conducted seminal research in many areas, including liver regeneration, the role of cytokines in liver disease, and hepatocellular cancer.

Few people have played a more important a role in transforming Duke into a truly global institution than Michael Merson. An international leader in global health and the founding director of the Duke Global Health Institute, Merson has extended the reach of the university, including the School of Medicine, into the farthest corners of the planet.

The NIH has announced that there will be significant changes to its grant application forms (Forms-E) and application guide instructions for all human subjects research proposals with due dates on or after January 25, 2018. A high-level summary of these changes is available on the NIH website.  If correct forms are not used, applications will be rejected without review.

The Duke Biorepository and Precision Pathology Center (BRPC) will institute a new fee schedule beginning January 1, 2018 for Pathology Reviews.    This new fee schedule applies only to Pathology Reviews, which occur early in the IRB Review phase and are not included in BRPC study specific budget teams receive.  Pathology Review fees will be invoiced separately to the study team through CoreResearch@Duke.   Please note Pathology Review fees are waived if a Faculty Pathologist is a listed as a collaborator on the protocol.  The new fee sched

OSP has announced updates to Duke’s post-award financial management processes, which were implemented in October.  Reach out to your OSP liaison and/or implementation team representative with any questions. Project Balance Netting

Five years after sharing the 2012 Nobel Prize in Chemistry with his former student, Stanford’s Brian Kobilka, Robert Lefkowitz of the Duke University Medical Center continues lab work. At age 75, he’s still building on the groundbreaking discoveries that reveal the functions of G protein-coupled receptors which drive the effects of half of all medications.

Kampala, Uganda -  For the patients lucky enough to get it, brain surgery is only the beginning. Urgent medical care is needed to cope with the complications from the operation, from blood loss, to restoring consciousness and body temperature, to dealing with symptoms from nausea to vomiting. Yet in Mengo hospital and other locations in the developing world, this care is almost an afterthought. Intensive care teams dealing with surgery patients operate under heavy workloads, with fewer resources and equipment available than in developed countries, and with little training.

To address security risks to Duke’s network all mobile devices, including those provided by Sponsors for research purposes, that connect to the secure Duke Health wireless network will be required to install the new Duke Health Mobile Device Manager (MDM) by December 31, 2017. Enrollment is required for these devices to continue to connect to Duke systems.